Listed by the USPTO as JAVANMARD, SAHAR
Tech Center 1600 • Art Units: 1617 1622 1627
This examiner grants 65% of resolved cases
JAVANMARD, SAHAR is assigned to tech center 1600 and art unit 1617. The record includes 752 resolved cases, a 64.9% allowance rate, and a median of 1045 days to allowance. The 34.1% interview lift identifies examiner interviews as a meaningful factor in the profile's outcome data. Practitioners can use these figures to assess whether direct discussion should accompany written arguments and amendments.
The listed companies are Verastem Inc., Prilenia Neurotherapeutics Ltd., and Washington University. The associated firms are GOODWIN PROCTER LLP, COOLEY LLP, and BOZICEVIC, FIELD & FRANCIS LLP. Their prosecution histories may assist with research into pharmaceutical and biotechnology claim strategies, including how applicants address technical and therapeutic distinctions.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18553411 | COMPOSITIONS FOR BINDING SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1P1), IMAGING OF S1P1, AND PROCESSES FOR PREPARATION THEREOF | Non-Final OA | Washington University |
| 18506916 | aPKC INHIBITORS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE OR DISORDER | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 18257817 | ADMINISTRATION OF GLYCEROL TRIBENZOATE AND GLYCEROL PHENYLBUTYRATE FOR TREATMENT OF NEURODEGENERATIVE AND UREA CYCLE DISORDERS | Final Rejection | Rush University Medical Center |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy64.9% of resolved applications examined by Sahar Javanmard were allowed (752 resolved cases), compared with 34.1% across Art Unit 1617 over the last five years.
This examiner's interview lift is +34.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sahar Javanmard took 1,045 days on average from filing to allowance.
Sahar Javanmard examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
